Here, DAF (from humans) and CSP (from the human parasite P. falciparum) were introduced into a BDES vaccine, and its protective efficacy against challenge infections in mice with a transgenic parasite line expressing P. falciparum CSP via the natural infection route (mosquito bites) was evaluated. This evidence concerns the gene CD55 and infection.